Charles River Laboratories (CRL) reported $1.01 billion in revenue for the quarter ended September 2024, representing a year-over-year decline of 1.6%. EPS of $2.59 for the same period compares to $2.72 a year ago.The reported revenue represents a surprise of +3.33% over the Zacks Consensus Estimate of $977.22 million. With the consensus EPS estimate being $2.43, the EPS surprise was +6.58%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...